The store will not work correctly when cookies are disabled.
4-[Benzyl-(2-naphthylmethyl)-amino]-butyronitrile
ID: ALA566469
PubChem CID: 44473507
Max Phase: Preclinical
Molecular Formula: C22H22N2
Molecular Weight: 314.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N#CCCCN(Cc1ccccc1)Cc1ccc2ccccc2c1
Standard InChI: InChI=1S/C22H22N2/c23-14-6-7-15-24(17-19-8-2-1-3-9-19)18-20-12-13-21-10-4-5-11-22(21)16-20/h1-5,8-13,16H,6-7,15,17-18H2
Standard InChI Key: LUOWOCACBZBWAD-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
5.8994 0.0356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6114 0.4525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3286 0.0443 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0407 0.4612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3336 -0.7809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0508 -1.1891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0541 -2.0141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7705 -2.4222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4835 -2.0052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4758 -1.1758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7590 -0.7714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1853 0.4477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2004 -1.2026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9091 -0.7840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0357 1.2864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4782 -0.7946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4740 0.0278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7608 0.4335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0514 0.0179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0597 -0.8076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7735 -1.2096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7479 1.7034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7427 2.5286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7410 3.3502 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 12 2 0
12 17 1 0
1 2 1 0
16 13 1 0
6 7 2 0
13 14 2 0
14 1 1 0
3 4 1 0
4 15 1 0
7 8 1 0
16 17 1 0
8 9 2 0
17 18 2 0
3 5 1 0
18 19 1 0
9 10 1 0
19 20 2 0
2 3 1 0
20 21 1 0
21 16 2 0
10 11 2 0
15 22 1 0
11 6 1 0
22 23 1 0
5 6 1 0
23 24 3 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 314.43 | Molecular Weight (Monoisotopic): 314.1783 | AlogP: 5.15 | #Rotatable Bonds: 7 |
Polar Surface Area: 27.03 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 8.23 | CX LogP: 4.69 | CX LogD: 3.80 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.56 | Np Likeness Score: -1.05 |
References
1. Valant C, Maillet E, Bourguignon JJ, Bucher B, Utard V, Galzi JL, Hibert M.. (2009) Allosteric functional switch of neurokinin A-mediated signaling at the neurokinin NK2 receptor: structural exploration., 52 (19): [PMID:19746979] [10.1021/jm900671k] |